Skip to main content
Clinical Trials/NCT04507880
NCT04507880
Unknown
Not Applicable

A 2-Year Prospective Follow-up Study of the Global Unite Reverse Fracture Shoulder System for Proximal Humerus Fractures

Signe Rosner Rasmussen0 sites42 target enrollmentAugust 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Shoulder Fractures
Sponsor
Signe Rosner Rasmussen
Enrollment
42
Primary Endpoint
Change in Constant score (CS)
Last Updated
5 years ago

Overview

Brief Summary

The objective of this study is to evaluated the efficacy and safety of the reverse total shoulder prosthesis (RTSA) for complex proximal humerus fractures. The clinical results of RTSA will be compared to clinical results from a historical cohort, that received a hemiarthroplasty of the shoulder.

Registry
clinicaltrials.gov
Start Date
August 1, 2020
End Date
August 1, 2024
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Signe Rosner Rasmussen
Responsible Party
Sponsor Investigator
Principal Investigator

Signe Rosner Rasmussen

MD, orthopedic resident, principal investigator

Herlev and Gentofte Hospital

Eligibility Criteria

Inclusion Criteria

  • Fracture or fracture dislocation not suitable for non-operative treatment or for osteosynthesis due to displacement and comminution
  • Patients older than 65-years of age, or younger than 65-year of age if the surgeon assesses the physiological age as older.
  • All patients, regardless of age, with an insufficient or irreparable rotator cuff

Exclusion Criteria

  • Brachial plexus palsy
  • Previous ipsilateral fracture of clavicula, scapula, or proximal humerus
  • Cognitive disabilities or substance abuse enabling rehabilitation and follow-up
  • Patients without a Danish civil registration number

Outcomes

Primary Outcomes

Change in Constant score (CS)

Time Frame: The outcome is measured 3 months, 6 months, 1 year and 2 years after surgery

The CS consists of four parameters (pain, mobility, ADL, strength) assessing shoulder function after the treatment of shoulder injury, both subjectively and objectively. The scale rates from worst (0) to best (100) quality of shoulder function.

Secondary Outcomes

  • Change in Oxford Shoulder Score (OSS)(The outcome is measured 3 months, 6 months, 1 year and 2 years after surgery)
  • Change in EQ5D questionnaire(The outcome is measured 3 months, 6 months, 1 year and 2 years after surgery)
  • Change in Numeric Ranking Scale(The outcome is measured 3 months, 6 months, 1 year and 2 years after surgery)
  • Change in humeral tuberosities(The outcome is measured 3 months, 6 months, 1 year and 2 years after surgery)
  • Change in Western Ontario Osteoarthritis of the Shoulder Index (WOOS)(The outcome is measured 3 months, 6 months, 1 year and 2 years after surgery)
  • Complications(The outcome is registered 2 years after surgery)

Similar Trials